Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Lawrie, Stephen M.
Ingle, Gordon T.
Santosh, Celestine G.
Rogers, Andrew C.
Rimmington, J. Ewen
Naidu, Kaliprasad P.
Best, Jonathan J. K.
O'Carroll, Ronan E.
Goodwin, Guy M.
Ebmeier, Klaus P.
and
Johnstone, Eve C.
1995.
Magnetic Resonance Imaging and Single Photon Emission Tomography in Treatment-Responsive and Treatment-Resistant Schizophrenia.
British Journal of Psychiatry,
Vol. 167,
Issue. 2,
p.
202.
Bogerts, Bernhard
1995.
Neuropathology and structural brain imaging in schizophrenia.
Current Opinion in Psychiatry,
Vol. 8,
Issue. 1,
p.
29.
van Kammen, Daniel P.
Kelley, Mary E.
Yao, Jeffrey K.
Gilbertson, Mark W.
Gurklis, John A.
Inosaka, Takao
Saito, Hidemitzu
Peters, Jeffrey L.
and
Sato, Mitsumoto
1996.
Predicting haloperidol treatment response in chronic schizophrenia.
Psychiatry Research,
Vol. 64,
Issue. 1,
p.
47.
Meltzer, Herbert Y
1996.
Predictors of Response to Clozapine.
Psychiatric Annals,
Vol. 26,
Issue. 7,
p.
385.
Schröder, Johannes
Bubeck, Bernd
Silvestri, Simone
Demisch, Sibylle
and
Sauer, Heinrich
1997.
Gender differences in D2 dopamine receptor binding in drug-naive patients with schizophrenia: an [123I]iodobenzamide single photon emission computed tomography study.
Psychiatry Research: Neuroimaging,
Vol. 75,
Issue. 2,
p.
115.
Buckley, Peter F.
1997.
New Dimensions in the Pharmacologic Treatment of Schizophrenia and Related Psychoses.
The Journal of Clinical Pharmacology,
Vol. 37,
Issue. 5,
p.
363.
Schröder, Johannes
Silvestri, Simone
Bubeck, Bernd
Karr, Markus
Demisch, Sibylle
Scherrer, Sabine
Geider, Franz J
and
Sauer, Heinrich
1998.
D2 Dopamine Receptor Up-Regulation, Treatment Response, Neurological Soft Signs, and Extrapyramidal Side Effects in Schizophrenia: A Follow-Up Study with 123I-Iodobenzamide Single Photon Emission Computed Tomography in the Drug-Naive State and after Neuroleptic Treatment.
Biological Psychiatry,
Vol. 43,
Issue. 9,
p.
660.
Konicki, P.Eric
Kwon, Ken Y
Steele, Vickie
White, John
Fuller, Matthew
Jurjus, George J
and
Jaskiw, George E
2001.
Prefrontal cortical sulcal widening associated with poor treatment response to clozapine.
Schizophrenia Research,
Vol. 48,
Issue. 2-3,
p.
173.
Češková, Eva
Drybčák, Pavel
Hrobař, Petr
Lorenc, Miroslav
Procházková, Hana
and
Špaček, Josef
2001.
The changes of biological markers and treatment efficacy in schizophrenia.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 25,
Issue. 2,
p.
323.
Buchsbaum, Monte S
Shihabuddin, Lina
Hazlett, Erin A
Schröder, Johannes
Haznedar, Mehmet M
Powchik, Peter
Spiegel-Cohen, Jacqueline
Wei, Tsechung
Singer, Melissa B
and
Davis, Kenneth L
2002.
Kraepelinian and non-Kraepelinian schizophrenia subgroup differences in cerebral metabolic rate.
Schizophrenia Research,
Vol. 55,
Issue. 1-2,
p.
25.
Češková, Eva
Drybčák, Pavel
and
Lorenc, Miroslav
2002.
Biological markers and possibilities for predicting therapeutic results in schizophrenia.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 26,
Issue. 4,
p.
683.
Woolley, James
and
McGuire, Philip
2005.
Neuroimaging in schizophrenia: what does it tell the clinician?.
Advances in Psychiatric Treatment,
Vol. 11,
Issue. 3,
p.
195.
Das, Pritha
Lagopoulos, Jim
Sæther, Oddbjørn
and
Malhi, Gin S
2008.
Is computed tomography still useful as a neuroimaging tool in psychiatry?.
Expert Opinion on Medical Diagnostics,
Vol. 2,
Issue. 9,
p.
1003.
Breier, Alan
Liffick, Emily
Hummer, Tom A.
Vohs, Jenifer L.
Yang, Ziyi
Mehdiyoun, Nicole F.
Visco, Andrew C.
Metzler, Emmalee
Zhang, Ying
and
Francis, Michael M.
2018.
Effects of 12-month, double-blind N-acetyl cysteine on symptoms, cognition and brain morphology in early phase schizophrenia spectrum disorders.
Schizophrenia Research,
Vol. 199,
Issue. ,
p.
395.
Sarpal, Deepak K.
and
Malhotra, Anil K.
2020.
Neuroimaging in Schizophrenia.
p.
355.
eLetters
No eLetters have been published for this article.